Monday, October 26, 2026 · Daily editionET --:--:--

United States1 robot tracked

PROCEPT BioRobotics

PROCEPT BioRobotics makes AquaBeam and HYDROS (Aquablation), which is at stage 5 of 5: regulator-cleared or mass market.

Website: procept-biorobotics.com
Based in: United States
Latest milestone: 4 Aug 2026

01Robots

What PROCEPT BioRobotics makes

Each robot's stage is worked out from its dated, sourced milestones by the same published rules, whoever the maker is.

AquaBeam and HYDROS (Aquablation)Medical · Prostate surgery robotStage 5 of 5 · Regulator-cleared or mass marketAquaBeam and its newer version HYDROS are robots that treat an enlarged prostate. A surgeon plans the cut on a live ultrasound picture, and the robot then removes prostate tissue with a jet of water.Sold to hospitals in the US; more than 13,100 US procedures in April to June 2026.The full record

02Track record

Every dated event

4 Aug 2026Milestone
In April to June 2026, PROCEPT delivered 65 HYDROS robots in the US, 14 of them replacing older systems.
PROCEPT BioRobotics Q2 2026 results (SEC filing), 4 Aug 2026
4 Aug 2026Milestone
Revenue for April to June 2026 was $94.5 million, up 19% on a year earlier. The company still lost $26.9 million in the quarter.
PROCEPT BioRobotics Q2 2026 results (SEC filing), 4 Aug 2026
21 Aug 2024Milestone
By August 2024, PROCEPT said more than 400 of its robots were installed in US hospitals, after more than 50,000 procedures.
PROCEPT BioRobotics press release, 21 Aug 2024Company-reported
21 Aug 2024Regulator
PROCEPT said the FDA cleared HYDROS, its next-generation robot, through the 510(k) route. HYDROS adds AI help for planning the cut on ultrasound.
PROCEPT BioRobotics press release, 21 Aug 2024Company-reported
21 Dec 2017Regulator
The FDA cleared the AquaBeam System through the De Novo route (DEN170024) to remove prostate tissue for men with an enlarged prostate.
MassDevice, 21 Dec 2017 (FDA record DEN170024)
21 Dec 2017Milestone
The FDA used a 181-patient study called WATER to decide on the clearance.
MassDevice, 21 Dec 2017Company-reported

03Money

On the stock market

PROCEPT BioRobotics trades as PRCT on NASDAQ. PROCEPT BioRobotics press release, 14 July 2026

All robot stocks, funding and suppliers

Prices by TradingView, about 15 minutes delayed. Not investment advice.